ArticleVeterinary medicine and science2025
Central Nervous System Depression After Topical Administration of Brimonidine Eye Drops to Induce Vomiting in a Cat.
Article in Veterinary medicine and science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brimonidine stimulates the chemoreceptor trigger zone via alpha-2 adrenergic receptors in the postrema of the medulla, which triggers vomiting in cats. This case report details the occurrence of central nervous system (CNS) depression following brimonidine administration to induce vomiting in a cat that had ingested a toxic substance. A 12-year-old neutered male American Shorthair cat was presented to the hospital after ingesting two leaves of Anthurium polyschistum, which is toxic to cats. 0.15% of brimonidine eye drops intended for ocular administration were accidentally administered onto the upper eyelids, resulting in the administration of four drops in total. Three incidents of projectile vomiting were then observed 30 min after the brimonidine administration. The cat began to show signs of CNS depression, including deep sedation and respiratory depression after vomiting. Brimonidine use was the suspected aetiology of the CNS depression. Atipamezole (200 µg/kg) was administered intramuscularly; after 5 min, the clinical signs of the CNS depression resolved. This case suggests that while brimonidine may serve as an effective emetic agent in feline patients, its systemic effects, particularly CNS depression, warrant careful monitoring. The potential impact of higher concentrations and increased dosing volume remains uncertain, highlighting the need for further research to establish safe and standardized dosing guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.